Akira Kawasaki et al.

Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma

Future Oncol. 2025 May 27:1-11.
doi:10.1080/14796694.2025.2507561. Online ahead of print.